Tim Oqueka

Tim Oqueka

Auto-generated profile, based on publicly available information

Tim Oqueka

Abteilung für Pneumologie, Zentrum für Onkologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Deutschland

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2017 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
LHLars Harbaum
Lars Harbaum
KBKaaja M. Baaske
Kaaja M. Baaske
MSMarcel Simon
Marcel Simon
TOTim Oqueka
Tim Oqueka
Christoph SinningChristoph Sinning
Christoph Sinning
HKHans F.E. Klose
Hans F.E. Klose
Chronic inflammation emerges as a feature of the pathogenesis of pulmonary arterial hypertension (PAH) in experimental models. Alterations of circulating cell subsets have been observed in patients with PAH. We aimed to assess associations of the white blood cell count with disease severity and outcome in patients with PAH. The total and differential white blood cell count was related to functional parameters, pulmonary hemodynamics and transplantation-free survival in 77 patients with PAH in an observational single center study. An increased neutrophil/lymphocyte ratio was associated with poor World Health Organization functional class and shorter 6-minute walking distance, as well as with elevated right atrial pressure and high level of N-terminal prohormone of brain natriuretic peptide. During a median follow-up period of 31 months (range 16-56) 23 patients died and 2 patients were referred to lung transplantation. Using uni- and subsequent bivariate Cox proportional hazards analyses an increased neutrophil/lymphocyte ratio was associated with unfavorable transplantation-free survival independent of hemodynamic parameters and C-reactive protein. The prognostic implication sustained in subsets of patients with incident PAH and in the absence of cardiovascular risk factors. The results of this analysis indicate that a neutrophilic inflammation may be associated with clinical deterioration and poor outcome in patients with PAH. Assessing the composition of the differential white blood cell count may render prognostic information and could represent a step towards incorporating an inflammatory marker into the clinical management of patients with PAH.

11 November 2016 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
LHLars Harbaum
Lars Harbaum
EREmilia Renk
Emilia Renk
SYSara Yousef
Sara Yousef
AGAntonia Glatzel
Antonia Glatzel
NLNicole Lüneburg
Nicole Lüneburg
HKHans F.E. Klose
Hans F.E. Klose
Exercise training positively influences exercise tolerance and functional capacity of patients with idiopathic pulmonary arterial hypertension (IPAH). However, the underlying mechanisms are unclear. We hypothesized that exercise modulates the activated inflammatory state found in IPAH patients. Single cardiopulmonary exercise testing was performed in 16 IPAH patients and 10 healthy subjects. Phenotypic characterization of peripheral blood mononuclear cells and circulating cytokines were assessed before, directly after and 1 h after exercise. Before exercise testing, IPAH patients showed elevated Th2 lymphocytes, regulatory T lymphocytes, IL-6, and TNF-alpha, whilst Th1/Th17 lymphocytes and IL-4 were reduced. In IPAH patients but not in healthy subject, exercise caused an immediate relative decrease of Th17 lymphocytes and a sustained reduction of IL-1-beta and IL-6. The higher the decrease of IL-6 the higher was the peak oxygen consumption of IPAH patients. Exercise seems to be safe from an immune and inflammatory point of view in IPAH patients. Our results demonstrate that exercise does not aggravate the inflammatory state and seems to elicit an immune-modulating effect in IPAH patients.

4 August 2022 in Zeitschrift für Rheumatologie
Verified
Journal Article
Closed access
PDF file
TOTim Oqueka
Tim Oqueka
SGSören Galow
Sören Galow
MSMarcel Simon
Marcel Simon
AWAnna Weidmann
Anna Weidmann
NSNicole Stübiger
Nicole Stübiger
HKHans Klose
Hans Klose

5 February 2026 in Respiration
Verified
Journal Article
Open access
DKDirk Koschel
Dirk Koschel
FBFrancesco Bonella
Francesco Bonella
AGAndreas Günther
Andreas Günther
MKMichael Kreuter
Michael Kreuter
DPDavid Pittrow
David Pittrow
JBJürgen Behr
Jürgen Behr
Introduction: Sex-related differences in interstitial lung disease (ILD) phenotypes are well recognized, but it remains unclear whether sex itself independently influences outcomes in non-idiopathic pulmonary fibrosis (non-IPF) ILD once comorbidities, lung function, and treatment are considered. Methods: In the prospective INSIGHTS-ILD registry (data cut 17 September 2025), we compared men and women with non-IPF ILD using descriptive analyses and Cox models with prespecified adjustment steps: model A (age, comorbidity count, and smoking), model B (A + forced vital capacity [FVC] and diffusing capacity of the lung for carbon monoxide [DLCO]), and model C (B + antifibrotic therapy). Prespecified subgroup analyses included age strata (≤55 and >55 years) and ILD entities. Longitudinal FVC and DLCO trajectories were assessed over 24 months. Results: Among 883 patients (483 men and 400 women), exposures and disease entities differed significantly by sex: men reported more occupational/environmental exposures and had higher rates of fibrotic idiopathic interstitial pneumonia, whereas women more frequently had autoimmune-related ILD and a family history of ILD. Men had a higher comorbidity burden and more often received antifibrotic therapy at baseline. Survival was shorter in men (HR: 1.51; 95% CI: 1.03–2.21), but this association disappeared after adjustment in model A (HR: 1.04; 95% CI: 0.65–1.68), model B (HR: 1.03; 95% CI: 0.61–1.74), and model C (HR: 1.04; 95% CI: 0.62–1.77). Progression-free survival and transplant-free survival showed no consistent sex-related differences. Longitudinal FVC and DLCO declines were modest and largely parallel in both sexes, with no significant between-group differences. Findings were similar across age groups and ILD entities. Conclusion: Men and women with non-IPF ILD differ in exposures, phenotypes, and comorbidities, but after accounting for these factors, sex is not an independent predictor of survival or functional progression. Risk assessment should therefore primarily be based on objective disease characteristics rather than sex alone.

1 December 2016 in Archivos de Bronconeumología
Verified
Journal Article
Closed access
MSMarcel Simon
Marcel Simon
HIHarald Ittrich
Harald Ittrich
LHLars Harbaum
Lars Harbaum
TOTim Oqueka
Tim Oqueka
SKStefan Kluge
Stefan Kluge
HKHans F.E. Klose
Hans F.E. Klose

21 December 2020 in Respirology Case Reports
Verified
Journal Article
Open access
PDF file
TOTim Oqueka
Tim Oqueka
HKHans Klose
Hans Klose
CIChristof Iking‐Konert
Christof Iking‐Konert
USUlrike Schnoor
Ulrike Schnoor
SKStefan Kluge
Stefan Kluge
MSMarcel Simon
Marcel Simon
Key message: Granulomatosis with polyangiitis (GPA) is a potentially life‐threatening disease that affects all ages. As the disease may be rapidly progressive, the undelayed recognition of its inflammatory activity is critical. This is especially important in central airway involvement, which contributes to morbidity and mortality.